Herbas VPB

Print
EN | LT
Supplementary protection
LT - N-(cianometil)-4-(2-(4-morfolinofenilamino)pirimidin-4-il)benzamido hidrochlorido druskos
EN - N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BENZAMIDE HYDROCHLORIDE SALTS
SPC
(11) Number of the document
(68) Number of the document 3154950
(21) Application number for Supplementary Protection Certificate PA 2024 523
(22) Date of filing the application 2024-07-11
(41) Date of publication of the application 2024-07-25
Date of publication of SPC
(24) Date of coming into effect of SPC
Applicant
(71) GlaxoSmithKline LLC, Corporation Service Company, 251 Little Falls Drive, Wilmington DE 19808, US
Grantee
(73) GlaxoSmithKline LLC, Corporation Service Company, 251 Little Falls Drive, Wilmington DE 19808, US
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Number, date and code of the country of origin of the first authorization to place the medicinal or plant protection product on the market within regional economic community
(93) EU/1/23/1782, 2024-01-25
Name of the product protected by the basic patent
(95) Momelotinibas, įskaitant momelotinibo dihidrochlorido monohidratą
Legal status
SPC application published
Last update date 2024-07-24